JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME Activity
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Elhendy, A.
Right arrow Articles by Poldermans, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Elhendy, A.
Right arrow Articles by Poldermans, D.
Journal of Nuclear Medicine Vol. 43 No. 12 1634-1646
© 2002 by Society of Nuclear Medicine


Continuing Education

Dobutamine Stress Myocardial Perfusion Imaging in Coronary Artery Disease*

Abdou Elhendy, MD, PhD1, Jeroen J. Bax, MD, PhD2 and Don Poldermans, MD, PhD3

1 University of Nebraska Medical Center, Omaha, Nebraska
2 Leiden University Hospital, Rotterdam, The Netherlands
3 The Thoraxcenter, Rotterdam, The Netherlands

The accurate noninvasive diagnosis and functional evaluation of coronary artery disease is an important step in selecting the appropriate management strategy. Dobutamine stress myocardial perfusion imaging is an alternative to exercise in patients with limited exercise capacity. In many centers, the test is performed on patients who have a contraindication for vasodilator stress testing. Recent studies have shown hyperemia induced by the standard dobutamine-atropine stress test is not less than hyperemia induced by dipyridamole. The feasibility of the test is 90% and is often higher in patients without ß-blocker therapy. The safety of the test has been well studied and was also demonstrated in specific patients groups, such as patients with left ventricular dysfunction, the elderly, and heart transplant recipients. The diagnostic accuracy has been demonstrated in patients with and without myocardial infarction and in specific groups such as those with hypertension, left ventricular hypertrophy, and heart transplant recipients and after revascularization. The technique has a high sensitivity for prediction of functional recovery in patients with myocardial dysfunction referred for revascularization. The presence and severity of myocardial perfusion abnormalities assessed by this method are powerful predictors of cardiac events, incremental to clinical data. This article describes the methodology, safety, feasibility, diagnostic accuracy, and prognostic value of dobutamine stress myocardial perfusion imaging in patients with known or suspected coronary artery disease, with additional considerations for the application of the test in specific patient groups.

Key Words: dobutamine • stress tests • myocardial perfusion imaging • coronary artery disease




This article has been cited by other articles:


Home page
JNMHome page
O. Gaemperli, T. Schepis, I. Valenta, L. Husmann, H. Scheffel, V. Duerst, F. R. Eberli, T. F. Luscher, H. Alkadhi, and P. A. Kaufmann
Cardiac Image Fusion from Stand-Alone SPECT and CT: Clinical Experience
J. Nucl. Med., May 1, 2007; 48(5): 696 - 703.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Elhendy, A. F. Schinkel, J. J. Bax, and D. Poldermans
Risk Stratification With Electrocardiographic-Gated Dobutamine Stress Imaging
J. Am. Coll. Cardiol., October 3, 2006; 48(7): 1472 - 1472.
[Full Text] [PDF]


Home page
JNMHome page
A. Elhendy, A. F.L. Schinkel, R. T. van Domburg, J. J. Bax, R. Valkema, E. Biagini, and D. Poldermans
Prognostic Stratification of Obese Patients by Stress 99mTc-Tetrofosmin Myocardial Perfusion Imaging
J. Nucl. Med., August 1, 2006; 47(8): 1302 - 1306.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. M. Navare, D. Katten, L. L. Johnson, J. F. Mather, M. S. Fowler, A. W. Ahlberg, N. Miele, and G. V. Heller
Risk Stratification With Electrocardiographic-Gated Dobutamine Stress Technetium-99m Sestamibi Single-Photon Emission Tomographic Imaging: Value of Heart Rate Response and Assessment of Left Ventricular Function
J. Am. Coll. Cardiol., February 21, 2006; 47(4): 781 - 788.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
A. Elhendy, A. F.L. Schinkel, R. T. van Domburg, J. J. Bax, R. Valkema, A. Huurman, H. H. Feringa, and D. Poldermans
Risk Stratification of Patients with Angina Pectoris by Stress 99mTc-Tetrofosmin Myocardial Perfusion Imaging
J. Nucl. Med., December 1, 2005; 46(12): 2003 - 2008.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
A. Elhendy, A. Huurman, A. F.L. Schinkel, J. J. Bax, R. T. van Domburg, R. Valkema, E. Biagini, and D. Poldermans
Association of Ischemia on Stress99mTc-Tetrofosmin Myocardial Perfusion Imaging with All-Cause Mortality in Patients with Diabetes Mellitus
J. Nucl. Med., October 1, 2005; 46(10): 1589 - 1595.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
A. F.L. Schinkel, A. Elhendy, E. Biagini, R. T. van Domburg, R. Valkema, V. Rizello, C. Pedone, M. Simoons, J. J. Bax, and D. Poldermans
Prognostic Stratification Using Dobutamine Stress 99mTc-Tetrofosmin Myocardial Perfusion SPECT in Elderly Patients Unable to Perform Exercise Testing
J. Nucl. Med., January 1, 2005; 46(1): 12 - 18.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
L. P. Salm, J. J. Bax, H. W. Vliegen, S. E. Langerak, P. Dibbets, J. W. Jukema, H. J. Lamb, E. K.J. Pauwels, A. de Roos, and E. E. van der Wall
Functional significance of stenoses in coronary artery bypass grafts: Evaluation by single-photon emission computed tomography perfusion imaging, cardiovascular magnetic resonance, and angiography
J. Am. Coll. Cardiol., November 2, 2004; 44(9): 1877 - 1882.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. E. B. van der Burg, J. J. Bax, E. Boersma, E. K.J. Pauwels, E. E. van der Wall, and M. J. Schalij
Impact of Viability, Ischemia, Scar Tissue, and Revascularization on Outcome After Aborted Sudden Death
Circulation, October 21, 2003; 108(16): 1954 - 1959.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2002 by the Society of Nuclear Medicine.